SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-035058
Filing Date
2020-06-08
Accepted
2020-06-08 17:46:24
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3926
  Complete submission text file 0001209191-20-035058.txt   5369
Mailing Address C/O VAXGEN INC 1000 MARINA BLVD. #200 BRISBANE CA 94005
Business Address
PANEK JAMES P (Reporting) CIK: 0001217412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 20950218

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)